Doç. Dr. Fadime DEMİR

1. Dose–Response and survival analysis after transarterial radioembolization for intrahepatic cholangiocarcinoma: A multicenter multicompartment dosimetry study

SOYDAL Ç., ÖNEŞ T., BOZKURT M. F., IŞIK E. G., Selcuk N. A., COŞKUN N., et al.

European Journal of Nuclear Medicine and Molecular Imaging , cilt.53, sa.11, ss.6559-6568, 2026 (SCI-Expanded, Scopus)

2. Renal and hematologic toxicity profile of [177] Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT): A retrospective cohort study Perfil de toxicidad renal y hematológica de la terapia con radioligandos dirigida al PSMA marcada con 177Lu (177Lu-PSMA-RLT): estudio de cohorte retrospectivo

Yalçınkaya M., DEMİR F., KARAÇAVUŞ S., Demir M.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.45, sa.5, 2026 (SCI-Expanded, Scopus)

3. Artificial Intelligence in Preclinical Modeling Klinik Öncesi Modellemede Yapay Zeka

DEMİR F., Yıldız H., KARAÇAVUŞ S.

Nuclear Medicine Seminars , cilt.12, sa.2, ss.156-164, 2026 (Scopus)

4. Tc-99m DMSA Radiomics in CKD: Phenotype-Specific Cortical Signatures and a Morphological Predictor of Renal Function Decline

Demir M., Köylüce N., Eren D., Uludağ K., Gençer H., KARAÇAVUŞ S., et al.

Diagnostics , cilt.16, sa.9, 2026 (SCI-Expanded, Scopus)

5. Can 68Ga-PSMA-11 PET/CT renal uptake parameters predict renal function impairment?

DEMİR F., Demir M., KARAÇAVUŞ S., Yeşilyurt M. İ., Laçin M. B.

International Urology and Nephrology , cilt.58, sa.3, ss.1035-1041, 2026 (SCI-Expanded, Scopus)

6. Relationship between tumor parameters in Ga-68 PSMA PET/ CT and pathological grade grouping in patients with prostate cancer

DEMİR F., KARAÇAVUŞ S., Gençer H., Özdal A., Erdoğan Z., Çiftçi İ., et al.

International Journal of Radiation Research , cilt.23, sa.2, ss.277-281, 2025 (SCI-Expanded, Scopus)

7. Predictive value of 18F-FDG PET/CT tumor SUVmax value in terms of overall survival after neoadjuvant therapy in rectal cancer

DEMİR F., Kandemir O., Guler A.

Reports of Practical Oncology and Radiotherapy , cilt.30, sa.4, ss.455-461, 2025 (ESCI, Scopus)

8. The Prognostic Significance of Tumor SUVmax Value in Pre‑ and Post‑Chemoradiotherapy 18F‑FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma

Kandemir O., DEMİR F., Avcı G.

Nigerian Journal of Clinical Practice , cilt.27, sa.6, ss.748-753, 2024 (SCI-Expanded, Scopus)

9. An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer

Kandemir O., DEMİR F.

Current Radiopharmaceuticals , cilt.17, sa.1, ss.111-116, 2024 (SCI-Expanded, Scopus)

10. Comparison of Oral Health and Salivary Biomarkers in Children with Juvenile Idiopathic Arthritis and Healthy Individuals

Çalişkan C., DURMUŞ B., GÜNGÖRMEK H. S., DEMİR F., SÖZERİ B.

Nigerian Journal of Clinical Practice , cilt.26, sa.12, ss.1808-1816, 2023 (SCI-Expanded, Scopus)

11. Does Iron Deficiency Affect the Heart in Children?

DEMİR F., Kayali S., GÜRLEK GÖKÇEBAY D.

Journal of Pediatric Hematology/Oncology , cilt.44, sa.3, ss.84-88, 2022 (SCI-Expanded, Scopus)

12. Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis

SÖZERİ B., Kardeş E., Salı E., Çakır D., DEMİR F.

Clinical and Experimental Rheumatology , cilt.39, sa.4, ss.907-912, 2021 (SCI-Expanded, Scopus)

13. Benign early repolarization pattern: Is it really benign for children?

Kayalı Ş., DEMİR F., Koçak M., Karadeniz C.

Journal of Pediatric Research , cilt.8, sa.2, ss.171-175, 2021 (ESCI, Scopus, TRDizin)

14. Clinical course of COVID-19 in children with rheumatic disease under biologic therapy

DEMİR F., Ulu K., Caglayan S., Coskuner T., SÖZERİ B.

Clinical and Experimental Rheumatology , cilt.39, sa.1, 2021 (SCI-Expanded, Scopus)

15. Prognostic value of various metabolic parameters on pre-treatment 18F-FDG PET/CT in patients with stage I-III non-small cell lung cancer

DEMİR F., Yanarateş A.

International Journal of Radiation Research , cilt.18, sa.4, ss.799-807, 2020 (SCI-Expanded, Scopus)

Doç. Dr. Fadime DEMİR

Yayınlar & Eserler

1. Dose–Response and survival analysis after transarterial radioembolization for intrahepatic cholangiocarcinoma: A multicenter multicompartment dosimetry study

3. Artificial Intelligence in Preclinical Modeling Klinik Öncesi Modellemede Yapay Zeka

4. Tc-99m DMSA Radiomics in CKD: Phenotype-Specific Cortical Signatures and a Morphological Predictor of Renal Function Decline

5. Can 68Ga-PSMA-11 PET/CT renal uptake parameters predict renal function impairment?

6. Relationship between tumor parameters in Ga-68 PSMA PET/ CT and pathological grade grouping in patients with prostate cancer

7. Predictive value of 18F-FDG PET/CT tumor SUVmax value in terms of overall survival after neoadjuvant therapy in rectal cancer

8. The Prognostic Significance of Tumor SUVmax Value in Pre‑ and Post‑Chemoradiotherapy 18F‑FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma

9. An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer

10. Comparison of Oral Health and Salivary Biomarkers in Children with Juvenile Idiopathic Arthritis and Healthy Individuals

11. Does Iron Deficiency Affect the Heart in Children?

12. Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis

13. Benign early repolarization pattern: Is it really benign for children?

14. Clinical course of COVID-19 in children with rheumatic disease under biologic therapy

15. Prognostic value of various metabolic parameters on pre-treatment 18F-FDG PET/CT in patients with stage I-III non-small cell lung cancer

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Tez Danışmanlığı

Açık Erişim